Advanced in Lung Metastases

Dr. Lana D. Melendres-Groves

Pulmonary Medicine
Unm Medical Group Inc
2211 Lomas Blvd Ne, 
Albuquerque, NM 
Advanced in Lung Metastases
Unm Medical Group Inc
2211 Lomas Blvd Ne, 
Albuquerque, NM 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Lana Melendres-Groves is a Pulmonary Medicine provider in Albuquerque, New Mexico. Dr. Melendres-Groves is rated as an Advanced provider by MediFind in the treatment of Lung Metastases. Her top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Lung Metastases, and Interstitial Lung Disease.

Her clinical research consists of co-authoring 22 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pulmonary Medicine
Licenses
Internal Medicine in NM
Hospital Affiliations
Unm Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Western Sky Community Care
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER COMMERCIAL
View 3 Less Insurance Carriers -

Locations

UNM MEDICAL GROUP INC
2211 Lomas Blvd Ne, Albuquerque, NM 87106
Other Locations
UNM MEDICAL GROUP INC
800 Bradbury Dr Se, Suite 116, Albuquerque, NM 87106

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
Enrollment Status: Active_not_recruiting
Publish Date: June 24, 2025
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
Enrollment Status: Terminated
Publish Date: November 24, 2023
Intervention Type: Drug
Study Drug: Inhaled treprostinil solution
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
View 2 Less Clinical Trials

22 Total Publications

Exploring patient preferences regarding the use of combination therapy with endothelin receptor antagonist (ERA) + phosphodiesterase-5 inhibitors (PDE5i).
Exploring patient preferences regarding the use of combination therapy with endothelin receptor antagonist (ERA) + phosphodiesterase-5 inhibitors (PDE5i).
Journal: JHLT open
Published: November 24, 2025
Similar Doctors
Distinguished in Lung Metastases
Dr. Matthew R. Montoya
Pulmonary Medicine
Distinguished in Lung Metastases
Dr. Matthew R. Montoya
Pulmonary Medicine

Presbyterian Healthcare Services

5901 Harper Dr Ne, 
Albuquerque, NM 
 (5.0 miles away)
505-823-8888
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Matthew Montoya is a Pulmonary Medicine provider in Albuquerque, New Mexico. Dr. Montoya is rated as a Distinguished provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Cerebral Hypoxia, Lung Metastases, Emphysema, and Pulmonary Fibrosis. Dr. Montoya is currently accepting new patients.

Distinguished in Lung Metastases
Dr. Dureshahwar K. Fernandez
Pulmonary Medicine | Sleep Medicine | Intensive Care Medicine
Distinguished in Lung Metastases
Dr. Dureshahwar K. Fernandez
Pulmonary Medicine | Sleep Medicine | Intensive Care Medicine

St Vincent Hospital

465 Saint Michaels Dr, Suite 117, 
Santa Fe, NM 
 (54.7 miles away)
505-984-2600
Languages Spoken:
English, Hindi, Spanish, Urdu
See accepted insurances
Accepting New Patients
Offers Telehealth

Dureshahwar Fernandez is a Pulmonary Medicine specialist and a Sleep Medicine provider in Santa Fe, New Mexico. Dr. Fernandez is rated as a Distinguished provider by MediFind in the treatment of Lung Metastases. Her top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Obstructive Sleep Apnea, and Bronchiectasis. Dr. Fernandez is currently accepting new patients.

Distinguished in Lung Metastases
Dr. Helen K. Busby
Pulmonary Medicine
Distinguished in Lung Metastases
Dr. Helen K. Busby
Pulmonary Medicine
5th Ambulatory Care Ctr, 2211 Lomas Blvd. Ne, 
Albuquerque, NM 
 (0.1 miles away)
505-272-3840
Languages Spoken:
English
See accepted insurances

Helen Busby is a Pulmonary Medicine provider in Albuquerque, New Mexico. Dr. Busby is rated as a Distinguished provider by MediFind in the treatment of Lung Metastases. Her top areas of expertise are Pulmonary Veno-Occlusive Disease, Acute Interstitial Pneumonia, Lung Metastases, and Pulmonary Hypertension.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Melendres-Groves's expertise for a condition
ConditionClose
View All 10 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile